Results 111 to 120 of about 32,499 (205)

Pharmacokinetics of adjusted-dose 8-hourly lopinavir/ritonavir in HIV-infected children co-treated with rifampicin

, 2019
: Objectives: To evaluate the proportion of children with lopinavir C-min >= 1 mg/L when receiving a novel 8-hourly lopinavir/ritonavir dosing strategy during rifampicin co-treatment.
Van Rie, Annelies, Rabie, Helena, McIlleron, Helen, Rawizza, Holly, Zar, Heather, Wiesner, Lubbe, Zuidewind, Peter, Winckler, Jana   +7 more
core  

Integrated Computational Study Prioritizes Drug-like Para-Flavonoids as Candidate SARS-CoV-2 M^pro Inhibitors. [PDF]

Curr Issues Mol Biol
Alqahtani JH, Ouachekradi M, Abdelfattah B, Elrherabi A, J Alqahtani M, Miantezila Basilua J, Khibech O, Bouhrim M.   +7 more
europepmc   +1 more source

Multiclass HIV drug resistance: Case series of treatment-experienced PLHIV with resistance to all antiretroviral classes in Northern Uganda. [PDF]

IDCases
Kayinda F, Bakunzi LB, Okello E, Jurua C, Nasuuna EM.   +4 more
europepmc   +1 more source

Navigating Therapeutic Frontiers: A Meta-review and Meta-analysis of COVID-19 Treatment Options. [PDF]

J Res Pharm Pract
Mousavi S, Ardekani MB, Feizi A.
europepmc   +1 more source

QT interval prolongation and its related factors before and after receiving lopinavir-ritonavir in the COVID-19 era: a historical cohort study. [PDF]

Virus Res
Jangjou A, Izadpanah P, Moqhadas M, Faramarzi H, Fahimi MH, Ghazipoor H, Hamrah H, Kamyab H.   +7 more
europepmc   +1 more source

Repurposing anti-retroviral drugs to treat NF2-related tumours: a protocol for a phase 0 trial (RETREAT). [PDF]

BMJ Open
Campbell S, Beaney K, Hosking J, Sorrell L, Allgar V, Aspinall PJ, Ammoun S, Evans DG, Hanemann CO, Kingdon S.   +9 more
europepmc   +1 more source

Virologic Outcomes of Common First-Line Antiretroviral Regimens Among Adults with HIV - China, 2021-2023. [PDF]

China CDC Wkly
Jia H, Zhao Y, Guan Y, Liu J, Geng Y, Gan X, Liu Y.   +6 more
europepmc   +1 more source

Pharmacokinetics of Dexamethasone in Tuberculous Meningitis. [PDF]

Clin Infect Dis
Calderin JM, Resendiz-Galvan JE, Abdelgawad N, Davis A, Stek C, Wiesner L, Meintjes G, Wilkinson RJ, Denti P, Wasserman S.   +9 more
europepmc   +1 more source

Impact of Dolutegravir-, Lopinavir/Ritonavir-, and Efavirenz-Based Antiretrovirals on Piperaquine Pharmacokinetics in Ugandan Children Living with HIV. [PDF]

Clin Pharmacol Ther
Kajubi R, Koire M, Whalen ME, Orukan F, Okiring J, Marzan F, Richards K, Lier AJ, Goodwin J, Colt M, Pham X, He S, Chu DHT, Opira B, Kisitu GP, Sekabira R, Kekitiinwa A, Huynh D, Khoury M, Gallison K, Fotaki N, Mwima MW, Kamya MR, Aweeka FT, Parikh S, Huang L, Mwebaza N.   +26 more
europepmc   +1 more source

Multivariate control charts based on Mahalanobis distance for bivariate quality monitoring in petrochemical and pharmaceutical analyses. [PDF]

Anal Bioanal Chem
Ijiri JS, Gonzales PV, Lourenço FR, de Oliveira EC.   +3 more
europepmc   +1 more source